top of page
Title
WELCOME
COVID-19
More
Use tab to navigate through the menu items.
All Qs
Dalton LaBarge
A postmenopausal 63yF presents for evaluation after receiving a diagnosis of Estrogen Receptor Positive Stage III DCIS with regional lymph node involvement but no distant mets. She is consented for a modified radical mastectomy with axillary lymph node dissection. In reviewing the plan for adjuvant therapies she is concerned about the use of chemotherapeutic and radiation therapy. What is the best rationale for adjuvant medical therapy following surgical resection?
Correct Answer:
A
B
C
D
Explanation
Verify?
Yes
No
Submit
Success!
bottom of page
